|
SLC44A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.204200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.311780E-01 |
| Normal-vs-Stage2 |
6.634800E-01 |
| Normal-vs-Stage3 |
2.412400E-02 |
| Normal-vs-Stage4 |
1.738450E-01 |
| Stage1-vs-Stage2 |
5.493800E-01 |
| Stage1-vs-Stage3 |
2.216400E-01 |
| Stage1-vs-Stage4 |
7.811600E-01 |
| Stage2-vs-Stage3 |
1.988430E-01 |
| Stage2-vs-Stage4 |
5.152400E-01 |
| Stage3-vs-Stage4 |
5.503800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.795500E-02 |
| Normal-vs-AfricanAmerican |
5.094600E-01 |
| Normal-vs-Asian |
1.105760E-01 |
| Caucasian-vs-AfricanAmerican |
6.498800E-01 |
| Caucasian-vs-Asian |
8.140600E-01 |
| AfricanAmerican-vs-Asian |
5.660200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257900E-02 |
| Normal-vs-Female |
1.582430E-01 |
| Male-vs-Female |
1.498190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.245600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.050440E-01 |
| Normal-vs-Age(61-80Yrs) |
5.781800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.941800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.715200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.154600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.079900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.239200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.142200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.557990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.314200E-01 |
| Classical-VS-Follicular |
3.085600E-01 |
| Classical-VS-Other |
5.437000E-01 |
| Classical-VS-Normal |
2.450600E-01 |
| Tall-VS-Follicular |
7.678400E-01 |
| Tall-VS-Other |
8.764400E-01 |
| Tall-VS-Normal |
6.821800E-02 |
| Follicular-VS-Other |
7.886000E-01 |
| Follicular-VS-Normal |
7.832400E-02 |
| Other-VS-Normal |
2.382800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.449900E-02 |
| Normal-vs-N1 |
2.031400E-01 |
| N0-vs-N1 |
7.993200E-01 |
|
|
